The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Click here to watch it, free.
John L. Maldonado net worth and biography

John Maldonado Biography and Net Worth

Director of Syneos Health
John L. Maldonado serves as Independent Director of the Company. Since 2006, Mr. Maldonado has been a Managing Partner at Advent, a global private equity firm, focused on buyouts in the healthcare, financial and business services sectors. Prior to joining Advent, he worked at Bain Capital, Parthenon Capital and The Parthenon Group. Mr. Maldonado currently serves on the board of directors of ATI Holdings, Inc., a provider of outpatient physical therapy, where he serves on the Audit Committee and Compliance Committee. He also currently serves on the board of directors of AccentCare, Inc., a provider in post-acute healthcare services, where he serves on the Compensation Committee and Compliance Committee, as well as the board of directors of Definitive Healthcare, LLC, a healthcare data provider, where he serves on the Compensation Committee. Mr. Maldonado previously served on the boards of Genoa, a QoL Healthcare Company, and Cotiviti Holdings, Inc. (formerly NYSE:COTV). Mr. Maldonado received his Bachelor’s degree in mathematics, summa cum laude, from Dartmouth College and his MBA, with high distinction, as a Baker Scholar from Harvard Business School.

How do I contact John L. Maldonado?

The corporate mailing address for Mr. Maldonado and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected] Learn More on John L. Maldonado's contact information.

Has John L. Maldonado been buying or selling shares of Syneos Health?

John L. Maldonado has not been actively trading shares of Syneos Health during the last ninety days. Most recently, John L. Maldonado sold 448,942 shares of the business's stock in a transaction on Friday, May 14th. The shares were sold at an average price of $81.04, for a transaction totalling $36,382,259.68. Learn More on John L. Maldonado's trading history.

Who are Syneos Health's active insiders?

Syneos Health's insider roster includes Michael Brooks (Insider), John Dineen (Director), Linda Harty (Director), Michelle Keefe (Insider), Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), Matthew Monaghan (Director), and Jonathan Olefson (General Counsel). Learn More on Syneos Health's active insiders.

Are insiders buying or selling shares of Syneos Health?

During the last twelve months, insiders at the sold shares 9 times. They sold a total of 23,458 shares worth more than $1,741,262.57. The most recent insider tranaction occured on July, 28th when COO Michael Lee Brooks sold 1,002 shares worth more than $78,156.00. Insiders at Syneos Health own 0.3% of the company. Learn More about insider trades at Syneos Health.

Information on this page was last updated on 7/28/2022.

John L. Maldonado Insider Trading History at Syneos Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/14/2021Sell448,942$81.04$36,382,259.68View SEC Filing Icon  
3/3/2021Sell4,654,046$74.17$345,190,591.82View SEC Filing Icon  
See Full Table

John L. Maldonado Buying and Selling Activity at Syneos Health

This chart shows John L Maldonado's buying and selling at Syneos Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Syneos Health Company Overview

Syneos Health logo
Syneos Health, Inc. engages in the provision of outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC.
Read More

Today's Range

Now: $36.09
Low: $35.69
High: $36.48

50 Day Range

MA: $35.01
Low: $33.18
High: $36.93

2 Week Range

Now: $36.09
Low: $22.89
High: $92.62

Volume

868,877 shs

Average Volume

1,634,210 shs

Market Capitalization

$3.71 billion

P/E Ratio

13.12

Dividend Yield

N/A

Beta

1.63
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.